Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
3 hedge funds and large institutions have $8K invested in Kitov Pharma Ltd. Warrants in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
78% less capital invested
Capital invested by funds: $36K → $8K (-$28K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$885 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3 |
KTOVW Hedge Fund Activity: Q4 2019 in Review
3 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q4 2019, worth a combined $8K — down 78% from $36K a quarter earlier.
Fund positioning in KTOVW was balanced in Q4 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $885.
- 3 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q4 2019, down from 4 in Q3 2019.
- Funds reported $8K of Kitov Pharma Ltd. Warrants stock for Q4 2019, down 78% quarter-over-quarter.
- 0 funds opened new Kitov Pharma Ltd. Warrants positions in Q4 2019 and 0 closed out.
- The largest Kitov Pharma Ltd. Warrants seller in Q4 2019 was Susquehanna International Group, an estimated $885 sold.
Based on aggregated 13F filings for Q4 2019.